Cloning, pharmacological characterization, and genomic localization of the human creatine transporter.
Stuart Nash(Hospices Civils de Lyon), Marc G. Caron(Duke University), Suzanne Suter(Duke University), Paul Gregor(Duke University), Julie M. Rochelle(Duke Medical Center), Bruno Giros(Centre National de la Recherche Scientifique), Michael F. Seldin(University of California, Davis), Stephen F. Kingsmore(Rady Children's Hospital-San Diego)
PubMed
January 1, 1994
Cited by 151
Related Papers
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
|Nature|1990|2.6k
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
|Nature|1996|2.5k
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
|Nature Genetics|2003|1.8k
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k